Response of a nonmalignant pleural effusion to bevacizumab.
Pichelmayer
Oskar
O
Zielinski
Christoph
C
Raderer
Markus
M
D000368:Aged; D000686:Amyloidosis / Q000150:complications; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D004417:Dyspnea / Q000209:etiology; D006331:Heart Diseases / Q000150:complications; D006801:Humans; D008297:Male; D010996:Pleural Effusion / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D011859:Radiography; D042461:Vascular Endothelial Growth Factor A / Q000276:immunology*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab